ÉϺ£ÊÐÉúÀí¿ÆÑ§»á2023Äê¶ÈÀíÊ»áôßѧÊõ×êÑлáÔÚб¦GGÕÙ¿ª

°ä²¼¹¦·ò£º2023-05-04Ͷ¸å£ºËïÕ¿ÈØ ä¯ÀÀ´ÎÊý£º

4ÔÂ27ÈÕÏÂÎç £¬ÉϺ£ÊÐÉúÀí¿ÆÑ§»áÔÚб¦GGÀÖºõ¥ѧº£ÌüÕÙ¿ª2023Äê¶ÈÀíÊ»áôßѧÊõ×êÑлá¡£±¾´Î»áÒéÓÉÉϺ£ÊÐÉúÀí¿ÆÑ§»á¡¢Ð±¦GGҽѧԺ¡¢Ð±¦GGÐÔÃü¿ÆÑ§Ñ§Ôº¡¢ÉϺ£Æ÷¹Ù½¨¸´¹¤³Ì¼¼Êõ×êÑÐÖÐÐĹ²Í¬Ö÷°ì¡£

8C989DC4F3136A502AFAC1C3F0C_94D1ED6E_E352

      »áÒéÊ×ÏÈÕÙ¿ªÉϺ£ÊÐÉúÀí¿ÆÑ§»áµÚÊ®ËĽì»áÔ±´ú±í´ó»á £¬ÓÉÀ´×ÔÉϺ£¸÷Ëù¸ßУ¡¢¿ÆÑÐÔºËùµÄר¼Ò¼°»áÔ±´ú±í¹²¼Æ100ÓàÈ˲λá¡£ÉϺ£ÊÐÉúÀí¿ÆÑ§»áÀíʳ¤³Â˼·æ½ÌÊÚÔÚ»áÔ±´ú±í´ó»áÉÏ×÷Á˹ØÓÚÉϺ£ÊÐÉúÀí¿ÆÑ§»á»»½ì¹¤×÷µÄ´«µÝ £¬²¢×÷Ϊµ³µÄ¹¤×÷Ó××é×鳤×÷Á˹ØÓÚµ³µÄ¹¤×÷Ó××é»»½ì¼°µ³½¨¹¤×÷´«µÝ¡£ÉϺ£ÊÐÉúÀí¿ÆÑ§»áÑ¡¾Ù²úÉúµÚËÄÊ®½ìÀíÊ»á³ÉÔ±¹²¼Æ23ÈË¡¢¼àÊ»á³ÉÔ±¹²¼Æ3ÈË £¬²¢ÓÉÐÂÒ»½ìÀíÊ»áºÍ¼àÊ»áÑ¡¾Ù²úÉúÀíʳ¤¡¢¸±Àíʳ¤5ÈË¡¢¼àʳ¤1ÈË¡¢ÃØÊ鳤1ÈË¡£×îºó £¬Ô¬Ó×±ø½ÌÊÚ×÷Ϊ¼àÊ»á´ú±í×÷Á˹ØÓÚÉϺ£ÊÐÉúÀí¿ÆÑ§»á¼àÊ»Ṥ×÷µÄ´«µÝ¡£

091D84277FEB345082BD3349E0F_8D38C8B4_CEBB

ÔÚËæ¼´ÕÙ¿ªµÄÉϺ£ÊÐÉúÀí¿ÆÑ§»á2023Äê¶ÈѧÊõ×êÑлáÉÏ £¬ÝÓÈÆÉñ¾­¿ÆÑ§¡¢ÐÄѪ¹ÜÉúÀíѧºÍ´úлµ÷½ÚµÈÁìÓò·¢Õ¹ÁËÉî¿ÌµÄѧÊõ»áÉÌ £¬¹²ÓÐÎåλר¼Ò¾ÍÓйØÁìÓòµÄ×êÑгɾÍ×÷Á˻㱨 £¬²¢Óë²Î»áÈËÔ±½øÐÐÁË»¥»»ºÍ»áÉÌ¡£

19D8109290E5EE6941FC0BF37F5_B4BEEDB0_C09D

      Ê×ÏÈ £¬À´×Ô¸´µ©´óѧÄÔ¿ÆÑ§×êÑÐÔºµÄÎÌÊ·¾û½ÌÊÚ×÷ÁËÌâΪ¡°×ԸйâÊÓÍøÄ¤Éñ¾­½Úϸ°ûÔÚÇü¹â·¢Óý¼°½üÊÓÐγÉÖеÄ×÷ÓᱵĻ㱨 £¬½éÉÜÁ˸ÃÁìÓòµÄ×îÐÂ×êÑгɾÍ¡£½Ó×Å £¬À´×ÔÉϺ£½»Í¨´óѧµÄÈÖΰ·¼½ÌÊÚ×÷ÁËÌâΪ¡°Distribution and function of the nonclassical estrogen receptor GPER in gut and brain¡±µÄ»ã±¨ £¬Ì½ÇóÁ˷Ǿ­µäÐԴƼ¤ËØÊÜÌåÔÚ³¦Â·ºÍ´óÄÔÖеÄÉ¢²¼ºÍÖ°ÄÜ¡£Ëæºó £¬»ª¶«Ê¦·¶´óѧԬÓ×±ø½ÌÊÚ½éÉÜÁËËûÃÇÍŶӹØÓÚÓ×Êó¿Ö¸ßÉñ¾­»úÔìµÄ×êÑгɾÍ¡£ÔÚ¶ÌÔݲèЪ֮ºó £¬ÉϺ£ÖÐÒ½Ò©´óѧ³Â»á»¨¸±½ÌÊÚ×÷ÁËÌâΪ¡°GRK3½éµ¼¦Â1-ARÍÑÃôЧӦÓÕµ¼ÐÄÁ¦Ë¥½ßµÄ·Ö×Ó»úÔì×êÑÓ×±µÄ»ã±¨ £¬ÏòÓë»áÕß¾ßÌå½éÉÜÁËÓйØ×êÑнøÕ¹¡£½ô½Ó×Å £¬À´×ÔÉϺ£ÌåÓýѧԺµÄ¹ùÁÁ½ÌÊÚ½éÉÜÁËËûÃÇÍŶӹØÓÚÏßÁ£ÌåÄÚĤµ°°×Higd1aÔڻ¸ÄÉÆ·Ç¾Æ¾«ÐÔÖ¬·¾¸ÎÖеÄ×÷ÓúͻúÔìµÄ×êÑгɾÍ¡£×îºó £¬Ð±¦GGÍõÀö¾ý¸±½ÌÊÚ×÷ÁËÌâΪ¡°METTL14 is required for exercise-induced cardiac hypertrophy and protects against myocardial ischemia-reperfusion injury¡±µÄ»ã±¨ £¬ÏòÓë»áÕß½éÉÜÁ˻¶ÔÐÄÔàµÄ± £»¤×÷Óü°±í¹ÛÒÅ´«·Ö×Ó»úÔì¡£

Õâ´Î»áÒé²»½öÔ¼ÇëÀ´×ÔÉúÀíѧ¼°ÓйØÑ§¿ÆµÄ×ÊÉîѧÕß×öÌØÑû»ã±¨ £¬Í¬Ê±¼¤Àø¸÷µ¥ÔªÍƼöÓÅÁ¼µÄÇàÄêѧÕß×ö×êÑл㱨 £¬ÎªÉϺ£ÊÐÉúÀíѧ¼°ÓйØÁìÓòµÄ¿ÆÑм°½²ÊÚ¹¤×÷Õߴ»¥»»Æ½Ì¨ £¬¹²Ïíѧ¿Æ·¢Õ¹Ç°ÑسɾÍ¡£

¡¾ÍøÕ¾µØÍ¼¡¿